TW239861B - - Google Patents

Info

Publication number
TW239861B
TW239861B TW082102440A TW82102440A TW239861B TW 239861 B TW239861 B TW 239861B TW 082102440 A TW082102440 A TW 082102440A TW 82102440 A TW82102440 A TW 82102440A TW 239861 B TW239861 B TW 239861B
Authority
TW
Taiwan
Application number
TW082102440A
Other languages
Chinese (zh)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929206989A external-priority patent/GB9206989D0/en
Priority claimed from GB929217827A external-priority patent/GB9217827D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of TW239861B publication Critical patent/TW239861B/zh

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
TW082102440A 1992-03-31 1993-04-01 TW239861B (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929206989A GB9206989D0 (en) 1992-03-31 1992-03-31 Chemical compounds
GB929217827A GB9217827D0 (en) 1992-08-21 1992-08-21 Chemical compounds

Publications (1)

Publication Number Publication Date
TW239861B true TW239861B (en:Method) 1995-02-01

Family

ID=26300619

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082102440A TW239861B (en:Method) 1992-03-31 1993-04-01

Country Status (4)

Country Link
CN (1) CN1081677A (en:Method)
IL (1) IL105232A0 (en:Method)
MX (1) MX9301837A (en:Method)
TW (1) TW239861B (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032866A1 (en) * 2000-08-07 2005-02-10 Bonhomme Mireille Marguerite Jeanne The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
WO2024067304A1 (zh) * 2022-09-28 2024-04-04 瀚远医药有限公司 一种具有Sigma2和5HT2A抑制活性的化合物及用途

Also Published As

Publication number Publication date
IL105232A0 (en) 1993-07-08
CN1081677A (zh) 1994-02-09
MX9301837A (es) 1994-02-28

Similar Documents

Publication Publication Date Title
DK0551248T3 (en:Method)
BR9304651A (en:Method)
DK0574087T3 (en:Method)
DK0588007T3 (en:Method)
DK0571874T3 (en:Method)
DK0571172T3 (en:Method)
DK0576097T3 (en:Method)
DK0590732T3 (en:Method)
DE9207553U1 (en:Method)
AU632452B2 (en:Method)
AU631518B2 (en:Method)
AU2098792A (en:Method)
BRPI9204323A2 (en:Method)
AU2138992A (en:Method)
AU1136092A (en:Method)
AU1299692A (en:Method)
AU1300192A (en:Method)
AU1405592A (en:Method)
AU1707592A (en:Method)
AU1708392A (en:Method)
AU1711092A (en:Method)
AU1844392A (en:Method)
AU1933792A (en:Method)
AU2061492A (en:Method)
AU1281092A (en:Method)